Skip to content
Use caution Drug recall · FDA · Published September 29, 2014

Baxter Recalls Dopamine Hydrochloride Due to Sterility Risk

Baxter Healthcare Corp. recalls specific lots of Dopamine Hydrochloride and Dextrose injection due to potential lack of sterility from bag leaks.

🇺🇸 FDA recall #D-0004-2015DrugBaxter ›
Take action

Contact the company

Recalling firmBaxter Healthcare Corp.1 Baxter Pkwy · Deerfield, IL 60015-4625
✎ GovInfoNow plain-language explainer

Baxter Healthcare Corp. is recalling a small number of bags of Dopamine Hydrochloride and 5% Dextrose Injection, USP (200 mg per 250 mL). The recall addresses a manufacturing defect where a small cut in the solution bag may have caused a leak into the overpouch, leading to a lack of assurance of sterility. This issue affects bags with Lot number P303172 and an expiration date of 12/14. Read more at govinfonow.com/recall/45748-baxter-healthcare-corp-recalls-dopamine-hydrochloride-and-5-dextrose-inj.

Source Summary by GovInfoNow · govinfonow.com/recall/45748-baxter-healthcare-corp-recalls-dopamine-hydrochloride-and-5-dextrose-inj · Updated October 12, 2026 · FDA enforcement record: FDA #D-0004-2015

Cite this page

“Baxter Recalls Dopamine Hydrochloride Due to Sterility Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45748-baxter-healthcare-corp-recalls-dopamine-hydrochloride-and-5-dextrose-inj. Based on FDA recall #D-0004-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0004-2015%22&limit=1).

The FDA announced on Sept. 29, 2014, that Baxter Healthcare Corp. voluntarily recalled Dopamine Hydrochloride and 5% Dextrose Injection due to a lack of sterility assurance caused by a potential bag leak. The recall affects 11,808 bags distributed nationwide and in Canada.

How to tell if you have it

  • Brand: Baxter
  • Product: Dopamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only
  • Manufacturer: Baxter USA
  • NDC: 0338-1005-02
  • Lot#: P303172
  • Expiration: 12/14

The hazard

A small cut in the solution bag may have been introduced during manufacturing, resulting in a leak into the overpouch. This defect creates a lack of assurance of sterility for the affected units.

Context

GovInfoNow's records show Baxter Healthcare Corp. has 34 other recalls on record since Sept. 21, 2012. Other recent recalls include the Baxter Amia Dialysis Set recall on Sept. 1, 2017, and the Brevibloc Injection recall due to discoloration on April 12, 2016. Additional similar product recalls by Baxter occurred on Aug. 6, 2026, involving Vasopressin, Famotidine, and Dexmedetomidine Injections for CGMP deviations risk.

How to tell if you have this one

Check if you have Dopamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only, manufactured by Baxter USA. Specifically look for NDC 0338-1005-02, Lot number P303172, and an expiration date of 12/14.

  • Brand
    Baxter
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Identify the Product

    Verify if your inventory includes Dopamine Hydrochloride and 5% Dextrose Injection with NDC 0338-1005-02, Lot P303172, expiring 12/14.

  2. Check for Damage

    Inspect the bags for any small cuts or leaks that may have allowed solution to escape into the overpouch.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide and Canada” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Sep 29, 201412. FDA classified it Class II: Oct 2, 201423. Published in FDA’s Enforcement Report: Oct 8, 201434. FDA terminated the recall: Sep 30, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How many units are being recalled?

A total of 11,808 bags are included in this recall.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0004-2015 (September 29, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0004-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA